Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 2009 Marmara University Faculty of Medicine İç Hastalıkları
  • 2003 Marmara University Faculty of Medicine
Experience
  • 2021 Acıbadem Healthcare Services
  • 2016 - 2019 Marmara University Faculty of Medicine / Ürinerve Üreme Sistemleri Ders Kurulu Başkanı
  • 2016 Marmara University Faculty of Medicine İç Hastalıkları Department Faculty Member / Yardımcı Associate Professor
  • 2016 Marmara University Faculty of Medicine Fakülte Yönetim Kurulu Üyesi / Yrd. Doç. / Dr. Öğr. Üyeleri Temsilcisi
  • 2013 - 2016 Marmara University Faculty of Medicine İç Hastalıkları Department Hipertansiyon ve Ateroskeroz Ünitesi Yönetim Kurulu Üyesi
  • 2013 - 2016 Marmara University Faculty of Medicine İç Hastalıkları Department Öğretim Görevlisi / Uzman
  • 2010 - 2013 Süreyyapaşa Göğüs Hastalıkları ve Cerrahisi EAH / İç Hastalıkları Uzmanı
  • 2009 - 2010 NATO Rapid Deployable Corps-Türkiye, 3. Kolordu Komutanlığı, Tabip Asteğmen / Teğmen
  • 2004 - 2009 Marmara University Faculty of Medicine İç Hastalıkları Department / Araştırma Görevlisi
Memberships
  • İstanbul Tabip Odası
  • European Federation of Internal Medicine
  • European Respiratory Society
  • Türk Tabipler Birliği
  • Türk İç Hastalıkları Uzmanlık Association
PUBLICATIONS
  • Hac Döneminde Karşilaşilan Sağlık Riskleri - Health Risks of Muslim Pilgrimage. Nobel Medicus 2015; 11(2): 13-18 13-18 Ozan Kocakaya, Derya Kocakaya, Aslı Tufan, Altuğ Çinçin.
  • Association of Agt, Gnb3 and Enos Gene Polymorphisms with Cardiovascular Parameters in a Turkish Population with Essential Hypertension. Experimental and Clinical Cardiology 2014, Vol 20, Issue 9, Pages 4604-4613 Pinar Mega Tiber, Oya Orun, Ozan Kocakaya, Hulya Cabadak, Cevdet Nacar, Ali Serdar Fak, Beki Kan.
  • A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. Erol Avşar, Arzu Tiftikçi, Şule Poturoğlu, Yusuf Erzin, Ozan Kocakaya, et al.
  • Bortezomib: a new therapeutic option for POEMS syndrome. European Journal of Haematology. 2010, Cilt 84, Sayı 2, Sayfa 175177 Işık Kaygusuz, Hakan Tezcan, Mustafa Cetiner, Ozan Kocakaya, Ant Uzay, Mahmut Bayik
  • Effects of selective COX-2 inhibitors on the gastric permeability of sucrose: a controlled study with placebo and ibuprofen. European Journal of Gastroenterology & Hepatology.2003, Cilt 15, Sayı 4, Sayfa 403?406 Meltem Ekenel, Erol Avşar, Neşe İmeryüz, Meral Yüksel, Goncagül Haklar, Ozan Kocakaya, Nurdan Tözün.
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""